key: cord-0682509-73qqcdah authors: Kracalik, Ian; Mowla, Sanjida; Katz, Louis; Cumming, Melissa; Sapiano, Matthew R. P.; Basavaraju, Sridhar V. title: Impact of the early COVID‐19 pandemic on blood utilization in the United States: a time‐series analysis of data reported to the National Healthcare Safety Network Hemovigilance Module date: 2021-05-14 journal: Transfusion DOI: 10.1111/trf.16451 sha: 33ef06c45c23dec641ac5d9d4a56fc41cdefac48 doc_id: 682509 cord_uid: 73qqcdah INTRODUCTION: The coronavirus disease 2019 (COVID‐19) pandemic has disrupted healthcare services worldwide. However, little has been reported regarding the impact on blood utilization. We quantified the impact of COVID‐19 on blood utilization and discards among facilities reporting to the National Healthcare Safety Network Hemovigilance Module. METHODS: Facilities continuously reporting data, during January 2016–June 2020, on transfused and discarded blood components, stratified by component type (red blood cells [RBC], platelets and plasma), were included. Interrupted time‐series analysis with generalized estimating equations, adjusting for facility surgical volume and seasonality, was used to quantify changes in blood utilization and discards relative to a Centers for Medicare & Medicaid Services notification delaying non‐essential medical procedures (March 2020). RESULTS: Seventy‐two facilities included in the analyses, on average, transfused 44,548 and discarded 2202 blood components monthly. Following the March 2020 notification and after multivariable adjustment, RBC and platelet utilization declined, −14.8% (p < 0.001) and − 16.6% (p = 0.017) respectively. Discards increased for RBCs (49.0%, p = 0.013) and platelets (60.4%, p = 0.002). No statistically significant change in plasma was found. Following these abrupt changes, blood utilization and discards rebounded towards baseline with RBC use increasing by 5.7% (p < 0.001), and platelet and RBC discards decreasing −16.4% (<0.001) and − 12.7 (p = 0.001), respectively. CONCLUSION: Following notification delaying elective surgical procedures, blood utilization declined substantially while blood discards increased, resulting in substantial wastage of blood products. Ongoing and future pandemic response efforts should consider the impact of interventions on blood supply and demand to ensure blood availability. This article is protected by copyright. All rights reserved. The novel coronavirus disease 2019 pandemic caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has disrupted healthcare services worldwide. [1] [2] [3] In the United States, COVID-19 was declared a national emergency on March 13, 2020 . Shortly thereafter, the Centers for Medicare & Medicaid Services (CMS) issued recommendations to delay all non-essential medical procedures, resulting in the widespread cancellation of surgeries and nearly all elective procedures. 4 At the same time, healthcare utilization declined substantially as the number of COVID-19 hospitalizations surged. Beginning in March, reports indicated substantial declines in hospital admissions and emergency room visits for non-COVID related conditions, 5, 6 as well as disruptions to healthcare seeking behaviors such as routine vaccinations. 7 These disruptions have also impacted the blood supply. Because blood has a limited shelf life, the supply must be continually replenished, and demand anticipated. As the potential scope of the pandemic was recognized, U.S. blood collections increased in anticipation of need (unpublished data: Blood Centers of America). However, early in the pandemic, many mobile blood collections and donations were cancelled, impacting supply. 8 One study in Washington reported, during a two-week period early in the pandemic, a decline in blood donations and inpatient blood utilization. 8 Other jurisdictions reported >70% reductions in blood collections. 9 These findings suggest supply constraints were initially offset by corresponding declines in This article is protected by copyright. All rights reserved. demand due to the cancellation of surgeries and elective procedures in March 2020 as recommended by CMS. 4, 10 However, non-essential medical procedures quickly resumed the following month (April 2020), highlighting the uncertainties of the pandemic. Monitoring blood utilization in the United States is fragmented and involves several, public and private, organizations. While data collection systems such as the National Blood Collection and Utilization Survey (NBCUS) provide a comprehensive view of blood utilization nationally, this survey is only administered every two years. 11 Conversely, the National Healthcare Safety Network (NHSN) Hemovigilance Module (HM) created to monitor recipient transfusion-related adverse reactions includes a smaller number of facilities, but provides near real-time monthly reporting of blood components transfused and discarded. 12 Thus, data reported to NHSN HM can be harnessed to provide a snapshot of blood utilization and discards. Given the evolving nature of the COVID-19 pandemic and ongoing challenges maintaining an adequate blood supply, data on impact of interventions on blood utilization and discards are essential. The objective of this study was to quantify the impact of COVID-19 on blood utilization and discards using data reported to the NHSN HM. During January 2016-June 2020, data on monthly transfused blood components (blood utilization) and discarded blood components were obtained from the National Healthcare Safety An interrupted time series regression approach was used to quantify the impact of COVID-19 on blood utilization and discards. The month (March 2020) of the CMS notification, which recommended delaying all non-essential medical procedures and surgeries, was used as the inflection point. March 2020 also coincided with the declaration of a U.S. national emergency. Data were modeled as a time-series of overdispersed counts at each facility by using generalized estimating equations with a negative binomial distribution and a first-order autoregressive (AR-1) correlation structure. 13, 14 Six separate models were constructed: blood utilization and discards for RBCs, platelets and plasma. The interrupted time series was defined by two periods: pre-CMS notification (January 2016-February 2020) and post-CMS-notification (March 2020-June 2020). Models included an intercept, a secular time trend, a binary variable representing the impact of the March 2020 CMS notification (coded 1 post-CMS-notification, 0 otherwise) and the trend following CMS notification (coded 0 pre-CMS-notification, and sequentially thereafter). Models also included quarter of the year to account for seasonality and tercile of inpatient annual surgical procedures to account for differences in blood utilization by facility size. 13 The interaction between the binary CMS notification variable and inpatient surgical operations tercile was tested to assess differences in the impact of the CMS notification by facility surgical volume. Results were reported as the relative (percent) change in blood components used and Accepted Article discarded was calculated using the following formula: ( − 1) * 100. All models were run using SAS v9.4 (SAS Institute, NC, USA). During January 2016-June 2020, 179 facilities reported data to the NHSN HM. Of these, 107 were excluded because they did not report data every month during the study period. Seventy-two facilities included in the analyses during the study period reported a total of 2,639,854 blood components transfused and 146,494 blood components discarded. These facilities were in eight of 10 HHS regions with most facilities located in the state of Massachusetts. Table 1 shows the average monthly number of blood components transfused by the 72 facilities included in the analysis during January 2016-June 2020, by component type, surgical volume, and HHS region. Most transfused components, on average, were RBCs (29,616; 66%). A greater number of components were transfused in high surgical volume facilities (34,825; 78%) than in low and medium surgical volume facilities ( Table 1) . The observed number of monthly transfused components, by component type, relative to the CMS notification delaying non-essential medical procedures are shown in Figure 1 . Following the CMS notification to delay all non-essential medical services, facilities reporting to NHSN HM showed a decline in transfused components. The lowest monthly number of transfused components occurred in April 2020 for all component types, except PR-platelets. Beginning in May 2020, the blood utilization rebounded towards baseline, although during the study period transfusions did not recover to pre-COVID-19 levels ( Figure 1 ). This article is protected by copyright. All rights reserved. Table 2 displays the average monthly number of blood components discarded, during January 2016-June 2020, by component type, surgical volume, and HHS region. Most discarded components, on average, were RBCs (43%, 852) and plasma (38%, 772). More components were discarded in high surgical volume facilities (1,641; 82%) than in low and medium surgical volume facilities. The ratio of average monthly components discarded to the average number of components transfused, shows a higher proportion of plasma (12%) were discarded than platelets (7%) and RBCs (3%). The observed monthly number of discards by component type, relative to the timing of the CMS recommendation which delayed non-essential surgery is shown in Figure 3 . A sharp rise in platelet discards occurred beginning in March and peaked in April 2020 ( Figure 3B ). Beginning in May 2020, discards declined, trending towards historical baselines for all components. Results of the interrupted time-series analysis with generalized estimating equations adjusting for quarter of the year and surgical volume tercile is shown in Supplemental Table 1 . Estimated percent changes in blood utilization after adjustment for quarter and surgical volume are shown in Table 3 . There was a statistically significant decline in the use of RBCs and was no statistically significant interaction between annual inpatient surgical volume tercile and the binary CMS notification variable. Estimated percent changes in blood discards after adjustment for quarter and surgical volume are shown in Table 4 . There was a statistically significant increase in discards of RBCs This article is protected by copyright. All rights reserved. infrastructure to communicate across all levels of the blood component supply chain to rapidly respond to evolving needs. 8, 10 Studies have shown public health emergencies and disasters have resulted in disruptions of blood transfusion services. Previous pandemics, including SARS and H1N1 pandemic influenza, were associated with a reduction in blood utilization secondary to declining healthcare utilization. [15] [16] [17] Similar to those previous pandemics, the present findings point to dramatic declines in non-essential surgeries and hospital admissions as the most plausible reasons for the abrupt decline in blood utilization and the associated increase in discards during the early COVID-19 epidemic among facilities in our study. 5, 18 Declines in blood utilization during the COVID-19 pandemic were also reported in other countries, including Singapore (>15%) and Saudi Arabia (>20%). 19, 20 Early in the pandemic, school and workplace closures in the United States were associated with a precipitous drop in the number of donors and blood collection events, which reduced the supply nationally; however, this was offset by declines in blood utilization due to reductions in surgical and non-surgical medical procedures. 8, 9, 20 While facility surgical volume was shown to be an indicator for blood utilization, this study found no statistically significant changes in blood utilization or discards by facility surgical volume, suggesting small and large facilities may have been proportionally impacted. 13 To date, >25 million COVID-19 cases have been identified in the United States, however, data indicate that hospitalized COVID-19 patients require fewer transfusions than other hospitalized patients. 10, 19, 21 Although the COVID-19 pandemic resulted in declines in elective and planned medical procedures, blood collection organizations and transfusion services must continue to maintain appropriate blood supplies to ensure adequacy for patients with hematologic malignancies, acute bleeding, and trauma where blood products can be emergently required. 9 However, ensuring an adequate supply is challenging given the unpredictability of emergent transfusion needs, as well as balancing the possibility of wastage and subsequent adverse economic impacts to blood centers or transfusing facilities. 22 have also impacted the changes that were observed here. For example, during the pandemic some facilities and organizations made recommendations to conserve blood. 23 The impact of these policies on the current finding cannot be independently assessed. These findings indicate that in addition to disruptions in healthcare services and blood collection, the initial COVID-19 pandemic period resulted in significant wastage of collected RBCs and platelets. Given the resource intense undertaking of blood donor recruitment, component manufacturing, and implementation of blood safety measures, and the significant cost of blood products, blood discards likely had adverse economic impact on blood collection organizations and transfusing hospitals. Under these economically challenging circumstances, blood collection organizations and transfusing hospitals are still required to ensure availability of blood products in emergencies, even if elective and planned procedures and inpatient admissions are suspended. These findings highlight the need for additional planning and preparedness measures to ensure a safe and adequate blood supply during pandemics such as COVID-19. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved. Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans Immediate and long-term impact of the COVID-19 pandemic on delivery of surgical services. The British journal of surgery COVID-19 disrupts vaccine delivery Cancellation of elective surgery and intensive care unit capacity in New York state: a retrospective cohort analysis Pandemic On Hospital Admissions In The United States: Study examines trends in US hospital admissions during the COVID-19 pandemic Impact of the COVID-19 Pandemic on Emergency Department Visits-United States Effects of the COVID-19 pandemic on routine pediatric vaccine ordering and administration-United States Prepare to adapt: blood supply and transfusion support during the first 2 weeks of the 2019 novel coronavirus (COVID-19) pandemic affecting Washington State Essential role of patient blood management in a pandemic: a call for action Effects of the COVID-19 pandemic on supply and use of blood for transfusion. The Lancet Haematology Slowing decline in blood collection and transfusion in the United States-2017 Transfusion-related adverse reactions: Data from the National Healthcare Safety Network Hemovigilance Module -United States Is surgical volume still the most accurate indicator of blood usage in the United States? Negative binomial regression Viral attacks on the blood supply: the impact of severe acute respiratory syndrome in Beijing Screening of blood donations for Zika virus infection-Puerto Rico The impact of H1N1 influenza A virus pandemic on the blood donations in Hyogo Prefecture Preserving elective surgeries in the COVID-19 pandemic and the future Blood and blood product use during COVID-19 infection Management of blood supply and demand during the COVID-19 pandemic in King Abdullah Hospital Blood transfusion utilization in hospitalized COVID-19 patients Crisis in the sustainability of the US blood system Blood Conservation Strategies During COVID-19 The authors thank facilities that participated in the NHSN Hemovigilance Module and reported these data. This article is protected by copyright. All rights reserved.